HIV-1 viral protein r in G2 arrest induction and disease progression / (2006)
Thesis (Ph.D.) -- Biomedical Sciences--Molecular Pharmacology and Experimental Therapeutics -- Mayo Clinic College of Medicine, Mayo Graduate School, 2006.
BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP (2006)
Yu, Xiaochun, Fu, Shuang, Lai, Maoyi, Baer, Richard, Chen, Junjie
BRCA1 (Breast Cancer Susceptibility Gene 1) possesses an N-terminal Ring domain and tandem C-terminal BRCT motifs. While the Ring domain has E3 ubiquitin ligase activity, the BRCA1 BRCT domains...
Lai, Maoyi, Zimmerman, Erik S., Planelles, Vicente, Chen, Junjie
The human immunodeficiency virus type 1 (HIV-1) protein Vpr (viral protein R) arrests cells in the G2 phase of the cell cycle, a process that requires activation of the ATR (ataxia-telangiectasia and...
Lai, Maoyi, Zimmerman, Erik S., Planelles, Vicente, Chen, Junjie
The human immunodeficiency virus type 1 (HIV-1) protein Vpr (viral protein R) arrests cells in the G2 phase of the cell cycle, a process that requires activation of the ATR (ataxia-telangiectasia and...
BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP
Yu, Xiaochun, Fu, Shuang, Lai, Maoyi, Baer, Richard, Chen, Junjie
BRCA1 (Breast Cancer Susceptibility Gene 1) possesses an N-terminal Ring domain and tandem C-terminal BRCT motifs. While the Ring domain has E3 ubiquitin ligase activity, the BRCA1 BRCT domains...